The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Chelation study for autism cancelled

     “The National Institute of Mental Health (NIMH) has decided that resources are better directed at this time to testing other potential therapies for autism spectrum disorders, and is not pursuing the additional review required to begin the study.”

    The study was given initial permission to proceed in 2006, but no patients were recruited.

    In 2007, the NIH reassessed the risk-benefit ratio of the proposed study and determined “there was no clear evidence for direct benefit to the children who would participate in the chelation trial and that the study presents more than a minimal risk.”

    Many parents and activists disagree. They believe that autism is triggered by exposure to mercury, a heavy metal, from childhood vaccines. But with the exception of some influenza vaccines, the use of mercury as a preservative has not been used in routinely recommended childhood vaccines since 2001, according to the U.S. Centers for Disease Control and Prevention.

    9/19/08 19:56 JR

    Leave a Comment

    You must be logged in to post a comment.